Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
about
The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.MicroRNA-3151 inactivates TP53 in BRAF-mutated human malignancies.Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.Nanochannel Electroporation as a Platform for Living Cell Interrogation in Acute Myeloid Leukemia.Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.MicroRNA regulation of F-box proteins and its role in cancer.MicroRNAs in Myeloid Hematological Malignancies.Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell Apoptosis.BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4.Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy.
P2860
Q36254225-6E88DA82-81D3-4CE3-BE5C-5BCF634AFC2CQ36371541-15FF7FD6-77D2-485F-892B-219AF9A0D338Q36688994-C0718731-4A7E-4C54-A7E1-85DCC8EE60A5Q37422939-9EF0DE1C-572C-4E89-9C37-9F2DCE76C987Q37644854-39C580E8-23EB-41BD-B179-D427FDB7DD91Q38577492-4FE26109-DE47-448C-992B-B679AE6CCF2BQ38599595-5E26EC49-18EF-4460-A0A2-F5586FCF6E1FQ38821561-81062A78-A5D4-4DB9-B4A3-0799053E3FBAQ40862157-943BDAFD-2D78-43AD-AB64-1C687D83842BQ44176860-A962AFD9-B248-4A83-AE52-E112755ABA24
P2860
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
@ast
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
@en
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
@nl
type
label
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
@ast
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
@en
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
@nl
prefLabel
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
@ast
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
@en
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
@nl
P2093
P2860
P50
P1433
P1476
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
@en
P2093
Ann-Kathrin Eisfeld
Benjamin Leffel
Christopher J Walker
Danilo Perrotti
Joseph Markowitz
Kevin W Hoag
Ramasamy Santhanam
Ravi Patel
Sebastian Schwind
Tiina M Jarvinen
P2860
P356
10.1126/SCISIGNAL.2004762
P577
2014-04-15T00:00:00Z